Carfilzomib: A cause of drug associated thrombotic microangiopathy

被引：28
|
作者：
Qaqish, Ibrahim [1 ]
Schlam, Ilana M. [2 ]
Chakkera, Harini A. [1 ]
Fonseca, Rafael [2 ]
Adamski, Jill [3 ]
机构：
[1] Mayo Clin Arizona, Dept Nephrol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA
[2] Mayo Clin Arizona, Dept Internal Med, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA
[3] Mayo Clin Arizona, Dept Lab Med & Pathol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA
来源：
TRANSFUSION AND APHERESIS SCIENCE | 2016年 / 54卷 / 03期
关键词：
Thrombotic microangiopathy; Therapeutic plasma exchange; Apheresis; BORTEZOMIB; PATIENT; EXPERIENCE;
D O I：
10.1016/j.transci.2016.03.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Carfilzomib is a selective proteosome inhibitor approved for treatment of relapsed and refractory multiple myeloma. Recent reports have linked exposure to carfilzomib with development of thrombotic microangiopathy (TMA). We describe two cases of biopsy proven thrombotic microangiopathy that occurred after the initiation of carfilzomib (dosed at 32 mg/m(2) and 23 mg/m(2), respectively) for relapsed multiple myeloma. Both patients were managed with discontinuation of the drug, therapeutic plasma exchange (TPE) and supportive care. Hemoglobin, platelets and renal function did not improve with TPE. TMA resolved with creatinine returning to baseline several weeks after discontinuation of the drug. The outcomes suggest that TPE is not beneficial for treating carfilzomib-induced TMA. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：401 / 404
页数：4
相关论文
共 50 条
  • [21] Carfilzomib-Induced Thrombotic Microangiopathy-Two Case Reports
    Attucci, Irene
    Pilerci, Sofia
    Messeri, Maria
    Pengue, Ludovica
    Tomasino, Giulia
    Caroti, Leonardo
    Vannucchi, Alessandro M.
    Antonioli, Elisabetta
    CANCER REPORTS, 2024, 7 (10)
  • [22] HIV associated thrombotic microangiopathy
    Ahmed, S
    Siddiqui, RK
    Siddiqui, AK
    Zaidi, SA
    Cervia, J
    POSTGRADUATE MEDICAL JOURNAL, 2002, 78 (923) : 520 - 525
  • [23] Drug-induced thrombotic microangiopathy
    Zakarija, A
    Bennett, C
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (06): : 681 - 690
  • [24] DRUG-INDUCED THROMBOTIC MICROANGIOPATHY
    Uriol, Miguel
    Perianez, Leonor
    Gomez, Gonzalo
    Ballester, Carmen
    Egea, Cristina
    Jimenez, Sonia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [25] Drug-induced thrombotic microangiopathy
    Alrammahi, A.
    Almukhtar, R.
    Qu, H.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S52 - S52
  • [26] “Unusual Cause Of Tophi With Renal Thrombotic Microangiopathy”
    Sahu K.K.
    Law A.D.
    Kumar G.
    Dhir V.
    Naseem S.
    Nada R.
    Varma S.C.
    Malhotra P.
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 (Suppl 1) : 100 - 103
  • [27] Drug-induced thrombotic microangiopathy
    Alrammahi, A.
    Almukhtar, R.
    Qu, H.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S51 - S51
  • [28] A Shearing Sensation: An Uncommon Cause of Thrombotic Microangiopathy
    Patel, Angeli
    Herrforth, Craig
    Rao, Abhinav K.
    Madden, Matthew Brooks
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [29] Transplant-associated thrombotic microangiopathy
    Renaudon-Smith, Edward
    De La Fuente, Josu
    Bain, Barbara J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (11) : 1160 - 1160
  • [30] Crescentic glomerulonephritis associated with thrombotic microangiopathy
    Arakawa M.
    Iichikawa K.
    Chiba J.
    Sasaki Y.
    Aizawa M.
    Sato H.
    Clinical and Experimental Nephrology, 2002, 6 (1) : 58 - 62
12345